PHASE |
ACTIVITY |
SCOPE OF I3CGLOBAL |
SCOPE OF MANUFACTURER |
PHASE 1 |
Legal Verification |
|
|
|
- Confirmation of production site address
- Law of Land Certificate
- Company Registration Certificate
- Incorporation Certificate.
|
|
- Confirmation of critical outsourcing locations
|
|
- Quality Management Certificate
|
Device Verification |
|
- Device Models confirmation
|
- Guidance, Review and Approval
|
|
- Guidance, Review and Approval
|
|
|
|
- Guidance, Review & Approval
|
- What is to be detected and/or measured
|
- Guidance, Review & Approval
|
- In-vitro medical device function
|
- Guidance, Review & Approval
|
- Specific disorder, condition, or risk factor
|
- Guidance, Review & Approval
|
- Process - automatic or not
|
- Guidance, Review & Approval
|
- Qualitative, semi-quantitative or quantitative
|
- Guidance, Review & Approval
|
|
- Guidance, Review & Approval
|
|
- Guidance, Review & Approval
|
|
- Guidance, Review & Approval
|
|
- Guidance, Review & Approval
|
|
- Guidance, Review & Approval
|
- Associated medicinal product(s)
|
- Guidance, Review & Approval
|
|
- Guidance, Review & Approval
|
- In vitro diagnostic medical device rationale
|
- Guidance, Review & Approval
|
- Device classification and justification
|
- Guidance, Review & Approval
|
- Key components description
|
- Guidance, Review & Approval
|
- Description of the specimen collection
|
PHASE 2 |
Confirmation of IVDR requirements and compliance issues |
- Identification of regulations
|
|
|
|
|
|
- Device specific standards
|
|
- Other applicable regulations if any
|
|
- Declaration of Conformity
|
|
- Documentation of additional declarations
|
|
PHASE 3 |
Design Controls
(Active, Non-Active Devices)
In line with ISO 13485 |
- Design and development procedure.
|
|
|
|
|
- Design & development inputs
|
|
- Design & development outputs
|
|
|
|
|
|
|
|
- Formulation / Drawings/ Specifications
|
|
|
|
- Design & development Review
|
Design Controls
(Software)
In line with ISO 62304 |
|
|
|
|
|
|
|
|
|
|
|
|
|
- Integration & Integration Testing
|
|
|
|
- Software Configuration Management
|
|
- Software Risk Management Process
|
|
- The code and code reviews
|
|
- Software validation and release.
|
PHASE 4 |
Risk Analysis & Usability |
- Development of Procedures and Templates
|
- Conduct of risk Analysis
- Team support and suggestions
|
|
|
|
- Risk Management File documentation
|
|
- Usability engineering procedure and template
|
- Team support and suggestions
|
|
- Usability engineering report
|
PHASE 5 |
Product verification and validation |
- Analytical performance characteristics
|
- Appoint 3rd party agencies if required) approval
|
- Guidance, Review & Approval
|
|
- Guidance, Review & Approval
|
|
- Guidance, Review & Approval
|
|
- Guidance, Review & Approval
|
- Metrological traceability of calibrator and control material values
|
- Guidance, Review & Approval
|
- Measuring range of the assay
|
- Scientific Validity Report conclusion
|
- Data generation and approval
|
- The analytical performance report
|
- Data generation and approval
|
PHASE 6 |
Production controls |
- Guidance, review, and approval
|
|
|
- Critical Process identification
|
|
- Critical Process validation protocol and reports
|
|
- Sterilization Process Validation Protocol
|
|
- Sterilization Process Validation Report
|
|
|
|
- Cleanroom Validation protocol and Records
|
|
- Bioburden protocol and Records
|
PHASE 7 |
Device Labelling |
- Guidance, review, and approval
|
- Primary / Secondary Labels including embossing’s submit as per guidance
|
Information For Use /
User manual |
- Guidance, review, and approval
|
- Develop and submit IFU / User manual as per guidance
|
Device Storage |
|
- Confirmation of storage time and condition
|
Lifetime / Shelf-Life |
- Guidance, review, and approval
|
- Lifetime / Shelf-Life Protocol and Reports
|
Packaging Controls
(Active, Non-Active Devices) |
- Guidance, review, and approval
|
|
- Packing Validation and Reports
|
- Transport Validation and Reports
|
PHASE 8 |
Quality Control |
|
- Specification of Finished Device
|
|
- Specification of Critical Raw Materials / Components
|
|
- Quality Plan / Control Plan
|
- Guidance, review, and approval
|
- Certificate of Analysis (COA)
|
- Guidance, review, and approval
|
|
|
|
|
- Electrical Safety Testing
|
PHASE 9 |
Clinical performance and clinical evidence |
- Clinical Performance Study Procedure
|
|
- Clinical Performance Study plan
|
|
- Clinical Performance Study Plan Report
|
- Organize the activities based on guidance
|
Post Market Surveillance and Vigilance Reporting |
- Develops or modifies the PMS procedure, if required
- Analysis based of collected PMS data based on the reactive and proactive sources selected by the manufacturer.
- Supports in selecting the sources from our PMS Plan provided by us.
- Guidance on Vigilance and CAPA if required.
- Decision on whether PMCF study needs to be conducted based on the feedback and risk classification
- Preparation of PMS report if Class I or PSUR if class IIa and above
- Vigilance Control Procedure as per MEDDEV 2.12-1 rev 8
|
- Extent necessary support by following PMS plan scheduled for the period.
- Collect PMS data based on the PMS sources chosen
- Organize Customer Feedback
- Organize Sales History and Sales volume data
- Organize User Feedback in the drafted and provided.
- Follow Vigilance and CAPAs if any required.
- Review and approve PMS plan, other evidence and PMSR/PSUR
|
Post Market Performance Follow-up |
- Prepares procedure for PMPF, if required.
- Analysis & and derive conclusion.
|
- Follow PMPF study based on Consultants Inputs
- Review and approve PMPF plan and PMPF Evaluation Report
|
PHASE 10 |
Notified Body Submission, Review and Site Audit and Issue of Certificate |
- Support identification of Notified Body
|
|
|
|
- Technical Documentation Submission
|
|
- Answering to Notified Body Review comments
|
- Team support and suggestions
|
|
|
|
- Accept the electronic and hard copies of the CE Certificate
|